AI assistant
Sending…
Q/C TECHNOLOGIES, INC. — Merger & Acquisition 2020
Nov 18, 2020
35313_rns_2020-11-18_f6afb318-14b8-4f81-bddb-5d9d32990e1d.zip
Merger & Acquisition
Open in viewerOpens in your device viewer
Filed by Akers Biosciences, Inc.
Pursuant to Rule 425 of the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Subject Company: MyMD Pharmaceuticals, Inc.
Commission File No.: 001-36268
Field: Page; Sequence: 1
Field: /Page
Field: Page; Sequence: 2
Field: /Page
Field: Page; Sequence: 3
Field: /Page
Field: Page; Sequence: 4
Field: /Page
Field: Page; Sequence: 5
Field: /Page
Field: Page; Sequence: 6
Field: /Page
Field: Page; Sequence: 7
Field: /Page
Field: Page; Sequence: 8
Field: /Page
Field: Page; Sequence: 9
Field: /Page
Field: Page; Sequence: 10; Options: Last
Field: /Page
More from Q/C TECHNOLOGIES, INC.
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 29
Annual Report
2026
Apr 15
Capital/Financing Update
2026
Feb 11
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Board/Management Information
2026
Jan 23
Regulatory Filings
2025
Dec 9
Capital/Financing Update
2025
Dec 1
Regulatory Filings
2025
Dec 1